Navigation Links
Zywave® II

ProductsZywave® II
Company Bausch & Lomb Storz
Item Zywave® II
Features 
  • Range: Spheric +6.00D to -12.00D, Cylinder 0.00D to 5.00D
  • Total wavefront analysis through the 5th order, 8mm pupil diameter
  • Assists in establishing a specific refractive treatment plan to correct an individual's particular aberrations
  • Based on Hartmann-Shack proven technology
  • Source: Laser diode
  • Wavelength: 785 nm
  • Operating type: Continuous wave
  • Power on cornea: <35uW (microwatts)
  • Min. beam diameter: 15 um in focus
  • Min. beam diameter: 15 um in focus
  • Footprint: 50 in. w x 32 in. d x 36 in. h
  • Temperature: in use - +18ºC to +24º C / storage: -10º C to +40ºC
  • Power Requirements: 115/230 VAC/4A 50/60 Hz
  • Description Trusted technology. Precisely measured. Zywave® II Wavefront Aberrometer offers precision diagnostics, measuring refractive error by identifying the total aberrations of the eye. As part of the Bausch & Lomb Zyoptix™ Diagnostic Workstation, Zywave II Wavefront Aberrometer provides patient-specific analysis that leads you to patient-specific solution.
    Info Bausch & Lomb Storz
    Customer Service: (585) 338-6000
    Web site: http://www.storz.com/

    Related medicine products :

    1. Carl Zeiss WASCA Analyzer/Aberrometer
    2. Z-View Aberrometer
    3. MAXWELL Optical Wavefront Aberrometer
    ... Elite II features a diagnostic ... of Glasgow,(UG) algorithm. Unlike competitive ... age, the UG,algorithm bases its ... gender, age, race, medication,and classification., ...
    ... The CSV-1000LanC 10% test face ... which uses the Landolt C ... test targets. The targets are ... test is very useful for ...
    The CSV-1000-1.5CPD is a special test face designed specifically for Food and Drug Administration clinical trials., ,At the recommended test distance of 8 feet, the gratings test one spatial frequenc...
    ... The CSV-1000RS test face is used widely ... presents ETDRS LogMAR acuity from 20/10 to ... at 12 cycles/degree. , ,The patient can ... for ETDRS acuity and contrast sensitivity. If ...
    Medicine Products:
    (Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
    (Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
    (Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
    Breaking Medicine News(10 mins):
    (Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
    (Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
    (Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
    Breaking Medicine Technology: